Assessing the Burden of Respiratory Syncytial Virus (RSV)

ConditionsRespiratory Syncytial Virus (RSV) Infection Acute Lower Respiratory Tract Infections Bronchiolitis Pneumonia Chronic Respiratory Conditions

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorAbu Dhabi Health Services Company

About this trial

This study examines the impact of Respiratory Syncytial Virus (RSV) on people of all ages, from infants to the elderly. It uses hospital records collected between January 2018 and December 2024 to understand:

* How often does RSV occur * Who is most at risk * The long-term and financial effects of RSV

Eligibility criteria

Qualifiers

Patients of all ages with a confirmed diagnosis of RSV infection

Patients admitted to a SEHA hospital or healthcare facility between January 2018 and December 2024

Patients with documented data in the SEHA electronic medical record (EMR) system

Disqualifiers

Patients with suspected RSV infection that is not laboratory-confirmed

Patients without sufficient data in the SEHA EMR system

Trial design

Treatments tested in this trial

Not listed

Trial groups

1,500 Participants

are grouped into 1 trial group

Sponsors and collaborators

Abu Dhabi Health Services Company

Lead sponsor

Source ClinicalTrials.gov